S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway
| dc.contributor.author | Sathe, Kinnari | |
| dc.contributor.author | Maetzler, Walter | |
| dc.contributor.author | Lang, Johannes | |
| dc.contributor.author | Mounsey, Ross Brian | |
| dc.contributor.author | Fleckenstein, Corinna | |
| dc.contributor.author | Martin, Heather Louise | |
| dc.contributor.author | Schulte, Claudia | |
| dc.contributor.author | Mustafa, Sarah | |
| dc.contributor.author | Synofzik, Matthis | |
| dc.contributor.author | Vukovic, Zvonimir | |
| dc.contributor.author | Itohara, Shigeyoshi | |
| dc.contributor.author | Berg, Daniela | |
| dc.contributor.author | Teismann, Peter | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.date.accessioned | 2013-04-04T15:35:05Z | |
| dc.date.available | 2013-04-04T15:35:05Z | |
| dc.date.issued | 2012-11 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 12 | |
| dc.format.extent | 1278729 | |
| dc.identifier | 19871852 | |
| dc.identifier | d379c263-7b2a-45dc-b7f6-aafe8920bfe3 | |
| dc.identifier | 84870168829 | |
| dc.identifier.citation | Sathe, K, Maetzler, W, Lang, J, Mounsey, R B, Fleckenstein, C, Martin, H L, Schulte, C, Mustafa, S, Synofzik, M, Vukovic, Z, Itohara, S, Berg, D & Teismann, P 2012, 'S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway', Brain, vol. 135, no. 11, pp. 3336-3347. https://doi.org/10.1093/brain/aws250 | en |
| dc.identifier.doi | 10.1093/brain/aws250 | |
| dc.identifier.iss | 11 | en |
| dc.identifier.issn | 0006-8950 | |
| dc.identifier.uri | http://hdl.handle.net/2164/2763 | |
| dc.identifier.vol | 135 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Brain | en |
| dc.subject | calcium-binding protein | en |
| dc.subject | MPTP | en |
| dc.subject | Parkinson's disease | en |
| dc.subject | S100B | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway | en |
| dc.type | Journal article | en |
